Palisade Bio Inc. Receives Nasdaq Notice for Non-Compliance with Minimum Bid Price Requirement

Reuters
03 May
<a href="https://laohu8.com/S/PALI">Palisade Bio Inc.</a> Receives Nasdaq Notice for Non-Compliance with Minimum Bid Price Requirement

Palisade Bio Inc. has announced that it received a notice from The Nasdaq Stock Market LLC regarding non-compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. The company's common stock has closed below the $1.00 per share minimum for 30 consecutive trading days. Currently, the listing of Palisade Bio's common stock remains unaffected, and it continues to trade under the symbol "PALI." The company now has 180 calendar days to regain compliance by achieving a closing bid price of at least $1.00 for a minimum of 10 consecutive business days. If necessary, an additional 180-day period may be granted, provided other listing standards are met. Palisade Bio is monitoring the situation and may explore options to address the deficiency.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palisade Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-008346), on May 02, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10